Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablation

Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein

(2017) Irene Marini et al.   Frontiers in Immunology

Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic intervention

(2016) Ryosuke Kojima et al.   ADVANCED DRUG DELIVERY REVIEWS

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits

(2016) Kole T. Roybal et al.   CELL

Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors

(2016) Leonardo Morsut et al.   CELL

Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors

(2016) Kole T. Roybal et al.   CELL

Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells

(2016) Mark B. Geyer et al.   CYTOTHERAPY

New Strategies for the Treatment of Solid Tumors with CAR-T Cells

(2016) Hao Zhang et al.   International Journal of Biological Sciences

Synthetic Biology—Toward Therapeutic Solutions

(2016) Viktor Haellman et al.   JOURNAL OF MOLECULAR BIOLOGY

Initiation of T cell signaling by CD45 segregation at 'close contacts'

(2016) Veronica T Chang et al.   NATURE IMMUNOLOGY

Driving CAR T-cells forward

(2016) Hollie J. Jackson et al.   Nature Reviews Clinical Oncology

Toxicity and management in CAR T-cell therapy

(2016) Challice L Bonifant et al.   Molecular Therapy-Oncolytics

Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo

(2016) Zhen Zhang et al.   PLoS One

Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy

(2015) Andreas Plückthun   Annual Review of Pharmacology and Toxicology

Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells

(2015) Ryosuke Kojima et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

CAR T-cell therapy: toxicity and the relevance of preclinical models

(2015) Milena Kalaitsidou et al.   Immunotherapy

Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems

(2015) Faranak Salman Nouri et al.   JOURNAL OF CONTROLLED RELEASE

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases

(2015) Miroslava Matuskova et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis

(2015) Lina Schukur et al.   Science Translational Medicine

Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors

(2014) Ikrame Amara et al.   BIOCHIMIE

Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal

(2014) J. S. Park et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EpCAM: Structure and function in health and disease

(2013) Ulrike Schnell et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Cytokine Levels in the Serum of Healthy Subjects

(2013) Giulio Kleiner et al.   MEDIATORS OF INFLAMMATION

Neural Stem Cell-Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies

(2013) K. S. Aboody et al.   Science Translational Medicine

Neural Stem Cell-Mediated Delivery of Irinotecan-Activating Carboxylesterases to Glioma: Implications for Clinical Use

(2013) Marianne Z. Metz et al.   Stem Cells Translational Medicine

Disentangling nestedness from models of ecological complexity

(2012) Alex James et al.   NATURE

Engineering death receptor ligands for cancer therapy

(2011) Harald Wajant et al.   CANCER LETTERS

Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases

(2011) Zhe-Sheng Chen et al.   FEBS Journal

Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

(2010) Dhanalakshmi Chinnasamy et al.   JOURNAL OF CLINICAL INVESTIGATION

Abrogation of Microsatellite-instable Tumors Using a Highly Selective Suicide Gene/Prodrug Combination

(2009) Cristina Ferrás et al.   MOLECULAR THERAPY